MBA from HEC Paris, Ph.D. in Chemistry from University of Minnesota, B.S. in Chemistry from Keio University. Upon receiving his degree in the U.S., he worked in chemical biology at The Scripps Research Institute. He then returned to Japan and engaged in drug discovery research at a pharmaceutical company. His interest in business led him to obtain an MBA in France, after which he joined a consulting firm, where he led projects such as opportunity assessment, market research, and licensing for global pharmaceutical and medical device companies. Drawn by the societal impact and technological promise, he became a part of Nanotis corporation in 2023.